QA: Rezolute Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2019_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.24609275165121006, 'aggregate_val': 28734206, 'exp_sum': 38113715, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 11454658, 'ResearchAndDevelopmentExpense': 17279548, 'remainder_Expenses': 9379509}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509261')"}

Graph

Absolute values for 0001509261, Rezolute Inc.

  xvar xval
0 AssetsCurrent 2,007,787
1 IntangibleAssetsNetIncludingGoodwill 37,030
2 PropertyPlantAndEquipmentNet 368,374
3 remainder_Assets 89,691
4 LiabilitiesCurrent 6,248,014
5 LiabilitiesNoncurrent 215,623
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,454,658
9 ResearchAndDevelopmentExpense 17,279,548
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,127,570
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,502,882
1 Liabilities 6,463,637
2 Expenses 28,734,206
3 Revenues 0
4 StockholdersEquity -3,960,755
5 NetIncome -29,861,776
6 ComprehensiveNetIncome -29,861,776
7 BaseVar 19,414,148
8 EconomicCapitalRatio -8.18

Edgar->Model Mapping

Feature Distribution

Change over Time